Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
SAN FRANCISCO, June 27, 2022 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “Critical Care Therapeutics – Global Market Trajectory & Analytics”. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
What’s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
Edition: 7; Released: January 2022
Executive Pool: 4597
Companies: 37 – Players covered include Abeona Therapeutics Inc.; ADMA Biologics, Inc.; Albumedix Ltd.; Asklepios Biopharmaceutical, Inc.; Aspen Pharmacare Holdings Ltd.; Baxter International Inc.; Bayer Healthcare AG; Bio Products Laboratory Ltd.; BioDelivery Sciences International, Inc.; Biogen, Inc.; BioMarin Pharmaceutical Inc.; Biotest Pharmaceuticals Corporation; Bristol-Myers Squibb Company; Catalyst Biosciences, Inc.; China Biologic Products Holdings, Inc.; Cosmo Pharmaceuticals NV; CSL Behring; Grifols International SA; Kamada Ltd.; Kedrion Biopharma, Inc.; Medxbio Pte. Ltd.; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Novo Nordisk A/S; Novozymes A/S; Octapharma AG; Portola Pharmaceuticals, Inc.; ProMetic Life Sciences, Inc.; rEVO Biologics, Inc.; Rockwell Medical; Sanquin; Shanghai RAAS Blood Products Co., Ltd.; Shire PLC; Teva Pharmaceutical Industries Ltd.; The Medicines Company; Thermo Fisher Scientific, Inc.; Ventria Bioscience and Others.
Coverage: All major geographies and key segments
Segments: Application (Deep Vein Thrombosis, Pulmonary Embolism (PE), Acute Coronary Syndrome, Other Applications); Drug Class (Albumin, Prothrombin Complex Concentrates, Antithrombin Concentrates, Other Drug Classes)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
ABSTRACT-
Global Critical Care Therapeutics Market to Reach $3.4 Billion by 2026
Amid the COVID-19 crisis, the global market for Critical Care Therapeutics estimated at US$2.9 Billion, is projected to reach a revised size of US$3.4 Billion by 2026, growing at a CAGR of 2.6% over the analysis period. Albumin, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$1.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 2.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $804.1 Million in 2021, While China is Forecast to Reach $671.3 Million by 2026
The Critical Care Therapeutics market in the U.S. is estimated at US$804.1 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$671.3 Million by the year 2026 trailing a CAGR of 4.9% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.
Antithrombin Concentrates Segment to Reach US$398.3 Million by the year 2026
In the global Antithrombin Concentrates segment, USA, Canada, Japan, China and Europe will drive the 1.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$260.9 Million will reach a projected size of US$298 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include – enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: ZA@StrategyR.com
LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter
https://twitter.com/marketbytes
Journalists & Media
Info411@strategyr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/valued-to-be-3-4-billion-by-2026–critical-care-therapeutics-slated-for-robust-growth-worldwide-301574699.html
SOURCE Global Industry Analysts, Inc.
